Yahoo
NasdaqCM - Nasdaq Real Time Price USD

PDS Biotechnology Corporation (PDSB)

1.4400 -0.1100 (-7.10%)
At close: October 30 at 4:00:00 PM EDT
1.4600 +0.0200 (+1.39%)
After hours: October 30 at 7:50:42 PM EDT
View in AlphaSpace Currency in USD All numbers in thousands
Financial statements are getting an update on November 9
Preview it now to see what’s changing.
Learn more
Breakdown
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Total Revenue
0
0
0
0
0
Operating Expense
27,832.6710
31,543.9590
36,321.1950
43,045.2340
41,672.4210
Operating Income
-27,832.6710
-31,543.9590
-36,321.1950
-43,045.2340
-41,672.4210
Net Non Operating Interest Income Expense
-5,839.2900
-4,121.3660
-2,158.3580
-1,302.9830
-381.3390
Pretax Income
-33,671.9610
-35,665.3250
-38,479.5530
-44,348.2170
-42,053.7600
Tax Provision
0
-1,169.8200
-869.1690
-1,406.0190
-1,198.9050
Net Income Common Stockholders
-33,671.9610
-34,495.5050
-37,610.3840
-42,942.1980
-40,854.8550
Diluted NI Available to Com Stockholders
-33,671.9610
-34,495.5050
-37,610.3840
-42,942.1980
-40,854.8550
Basic EPS
-0.64
-0.74
-1.03
-1.39
-1.43
Diluted EPS
-0.64
-0.74
-1.03
-1.39
-1.43
Basic Average Shares
52,600.8060
46,384.2800
36,452.7070
30,952.0600
28,599.2210
Diluted Average Shares
52,600.8060
46,384.2800
36,452.7070
30,952.0600
28,599.2210
Total Operating Income as Reported
-27,832.6710
-31,543.9590
-36,321.1950
-43,045.2340
-41,672.4210
Total Expenses
27,832.6710
31,543.9590
36,321.1950
43,045.2340
41,672.4210
Net Income from Continuing & Discontinued Operation
-33,671.9610
-34,495.5050
-37,610.3840
-42,942.1980
-40,854.8550
Normalized Income
-33,671.9610
-34,495.5050
-37,610.3840
-42,942.1980
-40,854.8550
Interest Income
817.9870
1,217.2410
2,514.8160
2,902.9390
935.1800
Interest Expense
6,657.2770
5,338.6070
4,673.1740
4,205.9220
1,316.5190
Net Interest Income
-5,839.2900
-4,121.3660
-2,158.3580
-1,302.9830
-381.3390
EBIT
-27,014.6840
-30,326.7180
-33,806.3790
-40,142.2950
-40,737.2410
EBITDA
-26,989.9200
-30,304.8820
-33,785.2670
-40,124.9360
-40,737.1550
Reconciled Depreciation
24.7640
21.8360
21.1120
17.3590
0.0860
Net Income from Continuing Operation Net Minority Interest
-33,671.9610
-34,495.5050
-37,610.3840
-42,942.1980
-40,854.8550
Normalized EBITDA
-26,989.9200
-30,304.8820
-33,785.2670
-40,124.9360
-40,737.1550
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2022 - 9/30/2015

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: